Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring.

about

Phase I study of veliparib in combination with gemcitabine.

P2860

Q47100777-C542925A-230D-4E40-8A6F-EB76341E7F62

P2860

Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring.

Item

http://www.wikidata.org/entity/Q55054679

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Rapid Homogeneous Immunoassay ...... r Therapeutic Drug Monitoring.

@en

Rapid Homogeneous Immunoassay ...... r Therapeutic Drug Monitoring.

@nl

type

Item

label

Rapid Homogeneous Immunoassay ...... r Therapeutic Drug Monitoring.

@en

Rapid Homogeneous Immunoassay ...... r Therapeutic Drug Monitoring.

@nl

prefLabel

Rapid Homogeneous Immunoassay ...... r Therapeutic Drug Monitoring.

@en

Rapid Homogeneous Immunoassay ...... r Therapeutic Drug Monitoring.

@nl

P1476

Rapid Homogeneous Immunoassay ...... r Therapeutic Drug Monitoring.

@en

P2093

Daniel Kozo

http://www.w3.org/2001/XMLSchema#string

Godefridus J Peters

http://www.w3.org/2001/XMLSchema#string

Irina Baburina

http://www.w3.org/2001/XMLSchema#string

Jan H Beumer

http://www.w3.org/2001/XMLSchema#string

Jodi B Courtney

http://www.w3.org/2001/XMLSchema#string

Julianne L Holleran

http://www.w3.org/2001/XMLSchema#string

Justin Jarrah

http://www.w3.org/2001/XMLSchema#string

Matt W Ross

http://www.w3.org/2001/XMLSchema#string

Michael Barrett

http://www.w3.org/2001/XMLSchema#string

Rebecca L Harney

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Dosing strategies for anticancer drugs: the good, the bad and body-surface area.

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.

Single-agent gemcitabine is active in previously treated metastatic breast cancer.

Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer.

Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma.

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study.

P304

235-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/FTD.0000000000000402

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28490046

http://www.w3.org/2001/XMLSchema#string

P932

5460533

http://www.w3.org/2001/XMLSchema#string

Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring.

about

P2860

P2860

Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932